Skip to main content

Table 4 Plasma hTERT mRNA in NPC patients at stages III and IV before and after treatment

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Group n hTERT mRNA (2-Ct) (X ± SD) F value P value
Before treatment 24 12.68 ± 3.08 98.528 <0.001
After chemotherapy 24 10.68 ± 2.48
After chemotherapy and radiotherapy 24 3.13 ± 1.69